The establishment of well-intentioned programs that fail to achieve their objectives and waste taxpayer dollars is an unfortunately frequent occurrence in the federal government. A prominent example of such an outcome is the 340B program, created by Section 340B of the Public Health Service Act of 1992, which requires pharmaceutical manufacturers participating in Medicaid to […]
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
Price controls will result in the loss of life due to a lack of future research and development.
The BBBA is more big government socialism, with a price tag of $4.9 trillion over 10 years.
The Build Back Better Act will cost lives by devastating the development of future cures.
Essentially it is Speaker Nancy Pelosi’s (D-Calif.) socialistic drug discount plan, H.R. 3, on steroids.
H.R. 3 exerts so much government authority over the pharmaceutical industry.
